China to Cut Value Added Tax on Rare Disease Drugs to 3%

February 13, 2019

Beginning on March 1, China will reduce the VAT on a group of 21 rare disease drugs from 16% to 3%. The government's announcement did not specify which drugs would be in the group. The move may signal a growing interest in drugs for rare diseases in China.

In May of 2018, China's National Medical Products Administration and the National Health Commission published a list of 121 rare diseases. This may make it easier to review and approve drugs for the diseases.


CP Wire

Submit an article to cafepharma's CP Wire. Click here to find out more.

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.